VRBCF (Virbac) Total Equity : $1,093 Mil (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Virbac Total Equity?

Virbac's total equity for the quarter that ended in Dec. 2024 was $1,093 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Virbac Total Equity Historical Data

The historical data trend for Virbac's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Total Equity Chart

Virbac Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Equity

Get a 7-Day Free Trial

797.10

819.43

889.08

992.28

1,092.57

Virbac Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Equity	Get a 7-Day Free Trial															889.08	972.82	992.28	1,070.23	1,092.57

Virbac Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Virbac's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	1935.625	-	843.057
	=	1,093

Virbac's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	1935.625	-	843.057
	=	1,093

Virbac Total Equity Related Terms

Thank you for viewing the detailed overview of Virbac's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Virbac Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

VIRPp:UK 0NM7:UK VIRP:France V16:Germany

Address

13e rue LID - BP 27, Carros, FRA, 06511

Website

https://www.virbac.com

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, and it also has its presence in Europe, North America, Far East Asia, India, Africa & Middle East (IMEA), Pacific, and Latin America.